Martina Martinovic
Overview
Explore the profile of Martina Martinovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galeota E, Bevilacqua V, Gobbini A, Gruarin P, Bombaci M, Pesce E, et al.
Clin Immunol
. 2024 Feb;
261:110164.
PMID: 38417765
Multiple vaccines have been approved to control COVID-19 pandemic, with Pfizer/BioNTech (BNT162b2) being widely used. We conducted a longitudinal analysis of the immune response elicited after three doses of the...
2.
Pagani L, Chinello C, Risca G, Capitoli G, Criscuolo L, Lombardi A, et al.
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36834989
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection leads to a wide range of clinical manifestations and determines the need for personalized and precision medicine. To better understand the biological determinants...
3.
Favalli A, Favalli E, Gobbini A, Zagato E, Bombaci M, Maioli G, et al.
Front Immunol
. 2022 Jun;
13:873195.
PMID: 35757699
COVID-19 has proven to be particularly serious and life-threatening for patients presenting with pre-existing pathologies. Patients affected by rheumatic musculoskeletal disease (RMD) are likely to have impaired immune responses against...
4.
Favalli E, Gobbini A, Bombaci M, Maioli G, Biggioggero M, Pesce E, et al.
Front Med (Lausanne)
. 2022 May;
9:923790.
PMID: 35602493
[This corrects the article DOI: 10.3389/fmed.2022.850858.].
5.
Favalli E, Gobbini A, Bombaci M, Maioli G, Biggioggero M, Pesce E, et al.
Front Med (Lausanne)
. 2022 Apr;
9:850858.
PMID: 35360719
Objectives: Given the high occurrence of asymptomatic subsets, the true prevalence of SARS-CoV-2 infection in rheumatic patients is still underestimated. This study aims to evaluate the seroprevalence of SARS-CoV-2 antibodies...
6.
Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano A, et al.
Sci Immunol
. 2021 Aug;
6(62).
PMID: 34376481
To understand how a protective immune response against SARS-CoV-2 develops over time, we integrated phenotypic, transcriptional and repertoire analyses on PBMCs from mild and severe COVID-19 patients during and after...
7.
Bonnal R, Rossetti G, Lugli E, De Simone M, Gruarin P, Brummelman J, et al.
Nat Immunol
. 2021 May;
22(6):735-745.
PMID: 34017124
Regulatory T (T) cells are a barrier for tumor immunity and a target for immunotherapy. Using single-cell transcriptomics, we found that CD4 T cells infiltrating primary and metastatic colorectal cancer...
8.
Passaro M, Martinovic M, Bevilacqua V, Hershberg E, Rossetti G, Beliveau B, et al.
Nucleic Acids Res
. 2020 Apr;
48(W1):W332-W339.
PMID: 32313927
Fluorescence in situ hybridization (FISH) is a powerful single-cell technique that harnesses nucleic acid base pairing to detect the abundance and positioning of cellular RNA and DNA molecules in fixed...
9.
Djekic L, Martinovic M, Ciric A, Fraj J
Pharm Dev Technol
. 2019 Dec;
25(3):332-339.
PMID: 31797708
The physical chitosan hydrogel, obtained by ionic gelation in lactic acid solution, was combined with biocompatible oil-in-water microemulsion with ibuprofen, to prepare composite hydrogels with 0.25-1% of the polymer and...
10.
Gruarin P, Maglie S, De Simone M, Haringer B, Vasco C, Ranzani V, et al.
Eur J Immunol
. 2018 Nov;
49(1):96-111.
PMID: 30431161
Whether human IL-10-producing regulatory T cells ("Tr1") represent a distinct differentiation lineage or an unstable activation stage remains a key unsolved issue. Here, we report that Eomesodermin (Eomes) acted as...